{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T05:39:20Z","timestamp":1769146760540,"version":"3.49.0"},"reference-count":26,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>Primary hyperparathyroidism (PHPT) is reported to be associated with an increased frequency of hypertension, however, information in this regard is sparse in relation to normocalcemic primary hyperparathyroidism (NPHPT).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>The aim of this study was to determine the association between NPHPT and blood pressure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design, Setting, and Patients:<\/jats:title>\n                  <jats:p>We retrospectively enrolled 940 patients who visited the Fujian Provincial Hospital between September 2010 and December 2013 with a measured serum parathyroid hormone (PTH) and calcium level. Among them, 11 patients were diagnosed with NPHPT, while 296 cases with normal PTH and albumin-adjusted serum calcium.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcomes Measures:<\/jats:title>\n                  <jats:p>Systolic blood pressure (SBP), diastolic blood pressure (DBP), intact serum PTH, and serum calcium were recorded.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>There were no significant differences between subjects identified with NPHPT and those with normal PTH in terms of age, sex, body mass index, serum calcium, 25-Hydroxyvitamin D, serum creatinine, fasting plasma glucose, triglycerides, total cholesterol, high density lipoprotein, and low density lipoprotein. The subjects with a diagnosis of NPHPT had higher levels of SBP (141.9 \u00b1 20.2 vs 131.2 \u00b1 16.5, P = .041) and DBP (85.2 \u00b1 12.4 vs 76.8 \u00b1 10.3, P = .026) than the subjects in the cohort with normal PTH. After adjustment for all potential confounders, risks (odds ratios and 95% confidence interval) of SBP and DBP in NPHPT patients were 1.035 (1.000, 1.071) and 1.063 (1.004, 1.125), respectively (P &amp;lt; .05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>The NPHPT had higher risk of high blood pressure than subjects with normal PTH. It is worth considering the necessity of more aggressive therapeutic intervention aimed to normalize PTH even if patients with NPHPT continue to be normocalcemic.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2014-4432","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T17:34:51Z","timestamp":1423589691000},"page":"2420-2424","source":"Crossref","is-referenced-by-count":56,"title":["Is Normocalcemic Primary Hyperparathyroidism Harmful or Harmless?"],"prefix":"10.1210","volume":"100","author":[{"given":"Gang","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Endocrinology (G.C., Y.X., T.X., J.Y., H.H., J.L., L.Li., W.L., L.Lin., L.S., L.C., J.W.), Fujian Provincial Hospital Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou,350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (G.C., Y.X., T.X., J.Y., H.H., J.L., L.Li., W.L., L.Lin., L.S., L.C., J.W.), Fujian Provincial Hospital Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou,350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongyao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Information (Q.Z.), Fujian Provincial Hospital, Fujian Medical University, Fuzhou, 350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (G.C., Y.X., T.X., J.Y., H.H., J.L., L.Li., W.L., L.Lin., L.S., L.C., J.W.), Fujian Provincial Hospital Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou,350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (G.C., Y.X., T.X., J.Y., H.H., J.L., L.Li., W.L., L.Lin., L.S., L.C., J.W.), Fujian Provincial Hospital Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou,350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (G.C., Y.X., T.X., J.Y., H.H., J.L., L.Li., W.L., L.Lin., L.S., L.C., J.W.), Fujian Provincial Hospital Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou,350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jixing","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (G.C., Y.X., T.X., J.Y., H.H., J.L., L.Li., W.L., L.Lin., L.S., L.C., J.W.), Fujian Provincial Hospital Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou,350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liantao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (G.C., Y.X., T.X., J.Y., H.H., J.L., L.Li., W.L., L.Lin., L.S., L.C., J.W.), Fujian Provincial Hospital Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou,350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (G.C., Y.X., T.X., J.Y., H.H., J.L., L.Li., W.L., L.Lin., L.S., L.C., J.W.), Fujian Provincial Hospital Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou,350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixiang","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (G.C., Y.X., T.X., J.Y., H.H., J.L., L.Li., W.L., L.Lin., L.S., L.C., J.W.), Fujian Provincial Hospital Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou,350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidan","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (G.C., Y.X., T.X., J.Y., H.H., J.L., L.Li., W.L., L.Lin., L.S., L.C., J.W.), Fujian Provincial Hospital Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou,350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangchun","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (G.C., Y.X., T.X., J.Y., H.H., J.L., L.Li., W.L., L.Lin., L.S., L.C., J.W.), Fujian Provincial Hospital Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou,350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junping","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (G.C., Y.X., T.X., J.Y., H.H., J.L., L.Li., W.L., L.Lin., L.S., L.C., J.W.), Fujian Provincial Hospital Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou,350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071615263122000_B1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0002-9343(69)90222-8","article-title":"Normocalcemic primary hyperparathyroidism","volume":"47","author":"Wills","year":"1969","journal-title":"Am J Med"},{"key":"2020071615263122000_B2","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615263122000_B3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1590\/S0004-27302013000600002","article-title":"Diagnosis and management of primary hyperparathyroidism\u2013a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism","volume":"57","author":"Sociedade Brasileira de Endocrinologia e Metabologia","year":"2013","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"2020071615263122000_B4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1507\/endocrj.EJ14-0004","article-title":"High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients","volume":"61","author":"Yagi","year":"2014","journal-title":"Endocr J"},{"key":"2020071615263122000_B5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.HYP.34.3.484","article-title":"Serum calcium and cardiovascular risk factors and diseases: the Troms\u00f8 study","volume":"34","author":"Jorde","year":"1999","journal-title":"Hypertension"},{"key":"2020071615263122000_B6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1530\/eje.0.1410350","article-title":"Population based study on serum ionised calcium, serum parathyroid hormone, and blood pressure. The Troms\u00f8 study","volume":"141","author":"Jorde","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2020071615263122000_B7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1046\/j.1365-2362.1998.00387.x","article-title":"Death risk factor analysis in primary hyperparathyroidism","volume":"28","author":"Hedb\u00e4ck","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"2020071615263122000_B8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2362.1998.00289.x","article-title":"Increased risk of death from primary hyperparathyroidism\u2013an update","volume":"28","author":"Hedb\u00e4ck","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"2020071615263122000_B9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.14310\/horm.2002.1370","article-title":"Normocalcemic primary hyperparathyroidism: a newly emerging disease needing therapeutic intervention","volume":"11","author":"D\u00edaz-Soto","year":"2012","journal-title":"Hormones (Athens)"},{"key":"2020071615263122000_B10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-09-1067","article-title":"Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"162","author":"Tordjman","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2020071615263122000_B11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/BF02067371","article-title":"Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension","volume":"16","author":"Sancho","year":"1992","journal-title":"World J Surg"},{"key":"2020071615263122000_B12","doi-asserted-by":"crossref","first-page":"E638","DOI":"10.1210\/jc.2012-4007","article-title":"Serum parathyroid hormone in relation to all-cause and cardiovascular mortality: the Hoorn study","volume":"98","author":"van Ballegooijen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615263122000_B13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"key":"2020071615263122000_B14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0008-6363(00)00130-9","article-title":"Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy","volume":"47","author":"Kosch","year":"2000","journal-title":"Cardiovasc Res"},{"key":"2020071615263122000_B15","first-page":"77","article-title":"Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems","volume":"21","author":"Gennari","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"2020071615263122000_B16","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1152\/ajpendo.2001.280.2.E209","article-title":"PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells","volume":"280","author":"Mazzocchi","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071615263122000_B17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/01.HYP.4.3.452","article-title":"Sympathetic system function and vascular reactivity in hypercalcemic patients","volume":"4","author":"Vlachakis","year":"1982","journal-title":"Hypertension"},{"key":"2020071615263122000_B18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.HYP.2.2.162","article-title":"Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak","volume":"2","author":"McCarron","year":"1980","journal-title":"Hypertension"},{"key":"2020071615263122000_B19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(99)01437-3","article-title":"High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group","volume":"354","author":"Cappuccio","year":"1999","journal-title":"Lancet"},{"key":"2020071615263122000_B20","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2013-1300","article-title":"Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615263122000_B21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615263122000_B22","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615263122000_B23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","article-title":"Normocalcemic Primary Hyperparathyroidism","volume":"16","author":"Cusano","year":"2013","journal-title":"J Clin Densitom"},{"key":"2020071615263122000_B24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jc.2008-1762","article-title":"Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Khan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615263122000_B25","first-page":"90","article-title":"Update on the use of cinacalcet in the management of primary hyperparathyroidism","volume":"35","author":"Marcocci","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"2020071615263122000_B26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/100\/6\/2420\/10423559\/jcem2420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/100\/6\/2420\/10423559\/jcem2420.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:39:40Z","timestamp":1594953580000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/100\/6\/2420\/2829660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,1]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2014-4432","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,1]]}}}